اثربخشی دارو درمانی بر کارکردهای اجرایی، مشکلات رفتاری و نشانگان بالینی اختلال نارسایی توجه/بیش فعالی

نوع مقاله : مقاله پژوهشی

نویسندگان

1 دانشجوی دکتری گروه روانشناسی، واحد کرمانشاه، دانشگاه آزاد اسلامی، کرمانشاه، ایران

2 دانشیار گروه روانشناسی، واحد کرمانشاه، دانشگاه آزاد اسلامی، کرمانشاه، ایران

3 استادیار گروه روانشناسی، واحد کرمانشاه، دانشگاه آزاد اسلامی، کرمانشاه، ایران

چکیده

مقدمه: اختلال نارسایی توجه-بیش فعالی از شایع ترین و پرچالش ترین اختلال های دوران کودکی و نوجوانی است. هدف از این پژوهش بررسی اثربخشی دارو درمانی بر کارکردهای اجرایی، مشکلات رفتاری و نشانگان بالینی اختلال نارسایی توجه/بیش فعالی می باشد.
روش کار: پژوهش از نوع آزمایشی با سنجش پیگیری سه ماهه با دو گروه آزمایش و کنترل (هر گروه 15 نفر) انجام شد. شرکت کنندگان به شیوه نمونه گیری هدفمند و براساس میزان هوش و نوع اختلال همتا شدند. گروه درمان­های دارویی تحت نظر روانپزشک به مدت 12 هفته روزانه دارو دریافت کردند. شرکت کنندگان با مقیاس سوانسون، نولان و پلهام ویرایش چهارم برای سنجش نشانه های بالینی ADHD، آزمون عصب روانشناختی کولیج جهت سنجش کارکردهای اجرایی و مقیاس خودگزارشی مشکلات رفتاری راتر فرم والدین مورد سنجش قرار گرفتند. از تحلیل واریانس چند متغیره (مانوا) برای بررسی فرضیه­های پژوهش استفاده شده است.
نتایج: نتایج پژوهش نشان داد که بین گروه تجربی و گروه کنترل در تمامی پس آزمون متغیرهای کارکردهای اجرایی، مشکلات رفتاری و نشانگان بالینی و مولفه های آنها تفاوت معنی داری وجود دارد (05/0P≤).
نتیجه گیری: باتوجه به نتایج به دست آمده، به نظر می رسد که دارو درمانی، مداخله ای اثر گذار برای درمان متغیرهای ذکر شده می باشد.

کلیدواژه‌ها


عنوان مقاله [English]

The effectiveness of drug therapy on executive functions, behavioral problems and clinical symptoms of attention deficit / hyperactivity disorder

نویسندگان [English]

  • Mohammad Torkman 1
  • Keivan kakabraee 2
  • Saeedeh Alsadat Hosseini 3
1 PhD Student, Department of Psychology, Kermanshah Branch, Islamic Azad University, Kermanshah, Iran
2 Department of Psychology, Kermanshah Branch, Islamic Azad University, Kermanshah, Iran.
3 Department of Psychology, Kermanshah Branch, Islamic Azad University, Kermanshah, Iran.
چکیده [English]

Introduction:Attention Deficit Hyperactivity Disorder is one of the most common and challenging disorders in childhood and adolescence. The aim of this study was to evaluate the effectiveness of drug therapy on executive functions, behavioral problems and clinical symptoms of attention deficit / hyperactivity disorder.
Methods: This experimental study was performed by measuring quarterly follow-up with two experimental and control groups (15 people in each group). Participants were matched by Purposive sampling method based on their level of intelligence and type of disorder. The psychotherapy group received medication daily for 12 weeks. Participants were assessed using the Swanson, Nolan, and Pelham Fourth Edition Scale to assess the clinical signs of ADHD, the College Neuropsychological Test to assess executive function, and the Rutterform Behavioral Problems Self-Report Scale. Multivariate analysis of variance (MANOVA) has been used to test the research hypotheses.
Results: The results showed that there was a significant difference between the experimental group and the control group in all post-test variables of executive functions, behavioral problems and clinical symptoms and their components (P≤0.05).
Conclusion: According to the results, it seems that drug therapy is an effective intervention to treat the mentioned variables.

کلیدواژه‌ها [English]

  • Attention Deficit / Hyperactivity Disorder
  • Drug Treatment
  • Executive Functions
  • Behavioral Problems
1. Polanczyk GV, Willcutt EG, Salum GA,
Kieling C, Rohde LA. ADHD prevalence estimates
across three decades: an updated systematic review
and meta-regression analysis. International journal of
epidemiology. 2014;43(2):434-42.
2. Skounti M, Philalithis A, Galanakis E.
Variations in prevalence of attention deficit
hyperactivity disorder worldwide. European journal
of pediatrics. 2007;166(2):117-23.
3. Association AP. Diagnostic and statistical
manual of mental disorders (DSM-5®): American
Psychiatric Pub; 2013.
4. Polanczyk GV, Salum GA, Sugaya LS, Caye
A, Rohde LA. Annual Research Review: A
meta‐analysis of the worldwide prevalence of mental
disorders in children and adolescents. Journal of child
psychology and psychiatry. 2015;56(3):345-65.
5. Sayal K, Prasad V, Daley D, Ford T, Coghill
D. ADHD in children and young people: prevalence,
care pathways, and service provision. The Lancet
Psychiatry. 2018;5(2):175-86.
6. Miller M, Hinshaw SP. Does childhood
executive function predict adolescent functional
outcomes in girls with ADHD? Journal of abnormal
child psychology. 2010;38(3):315-26.
7. Sella F, Re AM, Lucangeli D, Cornoldi C,
Lemaire P. Strategy selection in ADHD
characteristics children: A study in arithmetic.
Journal of attention disorders. 2019;23(1):87-98.
8. najarzadegan maryam, Nejati Vahid , Amiri
Nasrin. Effect of Cognitive Rehabilitation of
Working Memory in Reducing Behavioral Symptoms
(Attention Deficit and Impulsivity) of Children with
Attention Deficit and Hyperactivity Disorder Journal
of Neuropsychology. 2015;1(1):52-45.
9. Gray C, Climie EA. Children with attention
deficit/hyperactivity disorder and reading disability:
A review of the efficacy of medication treatments.
Frontiers in psychology. 2016;7:988.
10. Scheres A, Oosterlaan J, Geurts H, MoreinZamir S, Meiran N, Schut H, et al. Executive
functioning in boys with ADHD: primarily an
inhibition deficit? Archives of clinical
neuropsychology. 2004;19(4):569-94.
11. Serpell ZN, Esposito AG. Development of
executive functions: Implications for educational
policy and practice. Policy Insights from the
Behavioral and Brain Sciences. 2016;3(2):203-10.
12. Yasumura A, Omori M, Fukuda A, Takahashi
J, Yasumura Y, Nakagawa E, et al. Age-related
differences in frontal lobe function in children with
ADHD. Brain and Development. 2019;41(7):577-86.
13. Soriano-Ferrer M, Félix-Mateo V, Begeny J.
Executive function domains among children with
ADHD: Do they differ between parents and teachers
ratings? Procedia-Social and Behavioral Sciences.
2014;132:80-6.
14. Magnus W, Nazir S, Anilkumar AC, Shaban
K. Attention Deficit Hyperactivity Disorder (ADHD).
2017.
15. Bakhshayesh AR, Hänsch S, Wyschkon A,
Rezai MJ, Esser G. Neurofeedback in ADHD: a
single-blind randomized controlled trial. European
child & adolescent psychiatry. 2011;20(9):481-91.
16. Kirov R, Brand S. Sleep problems and their
effect in ADHD. Expert review of neurotherapeutics.
2014;14(3):287-99.
17. Campbell B, Kreider RB, Ziegenfuss T, La
Bounty P, Roberts M, Burke D, et al. International
Society of Sports Nutrition position stand: protein
and exercise. Journal of the international society of
sports nutrition. 2007;4(1):1-7.
18. Caye A, Swanson JM, Coghill D, Rohde LA.
Treatment strategies for ADHD: an evidence-based
guide to select optimal treatment. Molecular
psychiatry. 2019;24(3):390-408.
19. Wigal SB, Maltas S, Crinella F, Stehli A,
Steinhoff K, Lakes K, et al. Reading performance as
a function of treatment with lisdexamfetamine
dimesylate in elementary school children diagnosed
with ADHD. Journal of attention disorders.
2012;16(1):23-33.
20. Galland BC, Tripp EG, Taylor BJ. The sleep
of children with attention deficit hyperactivity
disorder on and off methylphenidate: a matched
case–control study. Journal of sleep research.
2010;19(2):366-73.
21. Sattari M, Hosseini SA, Rassafiani M,
Mahmoudi Gharaei MJ, Biglarian A, Tarkesh
Esfahani N. Prevalence of Comorbidity Behavioral
Disorders in Children With Attention Deficit
Hyperactivity. Archives of Rehabilitation.
2017;18(1):25-32.
22. Mohammad Esmaeel E. Adaptation and
Standardization of Child Symptom Inventory-4 (CSI4). Journal of Exceptional Children. 2007;7(1):79-96.
23. Shima Sahim. Investigation of short-scale and
boring forms of children for use in Iran Journal of
Social Sciences and Humanities, Shiraz University
1994;18:67-79.
24. Bussing R, Fernandez M, Harwood M, Hou
W, Garvan CW, Eyberg SM, et al. Parent and teacher
SNAP-IV ratings of attention deficit hyperactivity
disorder symptoms: psychometric properties and
normative ratings from a school district sample.
Assessment. 2008;15(3):317-28.
25. Coolidge FL, Thede LL, Jang KL. Are
personality disorders psychological manifestations of
executive function deficits? Bivariate heritability
evidence from a twin study. Behavior Genetics.
2004;34(1):75-84.
26. Alizadeh Hamid. Theoretical explanation of
Attention Deficit / Hyperactivity Disorder: Behavioral Inhibition Pattern and the nature of selfcontrol exceptional Children 2005;17(5):323-48.
27. Yosefi Farideh. Standardization of Rutter
Questionnaire to Assess the Behavioral and
Emotional Problems of Male and Female Students in
Shiraz Primary Schools. Social Sciences and
Humanities, Shiraz University 1988;13(1-2):171-94.
28. Taş Torun Y, Işik Taner Y, Güney E, İseri E.
Osmotic Release Oral System-Methylphenidate
Hydrochloride (OROS-MPH) versus atomoxetine on
executive function improvement and clinical
effectiveness in ADHD: A randomized controlled
trial. Applied Neuropsychology: Child. 2020:1-12.
29. Yildiz O, Sismanlar SG, Memik NC,
Karakaya I, Agaoglu B. Atomoxetine and
methylphenidate treatment in children with ADHD:
the efficacy, tolerability and effects on executive
functions. Child Psychiatry & Human Development.
2011;42(3):257-69.
30. Gau SS-F, Shang C-Y. Improvement of
executive functions in boys with attention deficit
hyperactivity disorder: an open-label follow-up study
with once-daily atomoxetine. International Journal of
Neuropsychopharmacology. 2010;13(2):243-56.
31. Brown TE, Holdnack J, Saylor K, Adler L,
Spencer T, Williams DW, et al. Effect of atomoxetine
on executive function impairments in adults with
ADHD. Journal of attention disorders.
2011;15(2):130-8.
32. Overtoom C, Verbaten M, Kemner C,
Kenemans J, Van Engeland H, Buitelaar J, et al.
Effects of methylphenidate, desipramine, and L-dopa
on attention and inhibition in children with attention
deficit hyperactivity disorder. Behavioural brain
research. 2003;145(1-2):7-15.
33. Khoushabi K, Shamsaee MM, Jadidi M,
Nikkhah H, Basteh Hoseini S, Malek Khosravi G. A
Comparative Study on the Effectiveness of Stimulant
Therapy (Ritalin) Neurofeedback, and Parental
Management Training and Interaction of the Three
Approaches on Improving ADHD and Quality of
Mother -Child Communication. Avicenna Journal of
Clinical Medicine. 2013;20(2):133-43.
34. Dodangi Nasrin, Habibi Nastaran.
Comparison of duloxetine and methylphenidate in the
treatment of children with attentiondeficit/hyperactivity disorder Tehran University
Medical Journal. 2016;74(3).
35. Owens J. Relationships between an ADHD
Diagnosis and Future School Behaviors among
Children with Mild Behavioral Problems. Sociology
of Education. 2020;93(3):191-214.
36. Häge A, Hohmann S, Millenet S,
Banaschewski T.
Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im
Kindes-und Jugendalter. Der Nervenarzt.
2020;91(7):599-603.
37. Bai G-n, Wang Y-f, Yang L, Niu W-y.
Effectiveness of a focused, brief psychoeducation
program for parents of ADHD children: improvement
of medication adherence and symptoms.
Neuropsychiatric Disease and Treatment.
2015;11:2721.